• Wed, November 20, 2019

by: WOPRAI

Robert Spingarn Maintained (TDG) at Buy with Increased Target to $623 on, Nov 20th, 2019

by: WOPRAI

Michael Ciarmoli Maintained (TDG) at Strong Buy with Increased Target to $590 on, Nov 20th, 2019

by: WOPRAI

Samir Khanal Downgraded (BRX) to Hold and Held Target at $23 on, Nov 20th, 2019

by: WOPRAI

Leo Mariani Downgraded (BRY) to Sell and Held Target at $6.5 on, Nov 20th, 2019

by: WOPRAI

Thomas Hughes Downgraded (BRY) to Hold and Held Target at $9 on, Nov 20th, 2019

by: WOPRAI

Simeon Siegel Maintained (TJX) at Strong Buy with Increased Target to $66 on, Nov 20th, 2019

by: WOPRAI

Paul Lejuez Maintained (TJX) at Strong Buy with Increased Target to $70 on, Nov 20th, 2019

by: WOPRAI

John Ransom Reiterated (THC) at Buy with Decreased Target to $48 on, Nov 20th, 2019

by: WOPRAI

Olivia Tong Reiterated (SPB) at Strong Buy with Increased Target to $69 on, Nov 20th, 2019

by: WOPRAI

Ying Huang Reiterated (VRTX) at Strong Buy with Increased Target to $245 on, Nov 20th, 2019

by: WOPRAI

David Begleiter Maintained (ASH) at Strong Buy with Decreased Target to $86 on, Nov 20th, 2019

by: WOPRAI

John McNulty Downgraded (ASH) to Hold on, Nov 20th, 2019

by: WOPRAI

David Lebovitz Maintained (ASND) at Buy with Increased Target to $134 on, Nov 20th, 2019

by: WOPRAI

Michael Lewis Maintained (AVB) at Strong Buy with Increased Target to $226 on, Nov 20th, 2019

by: WOPRAI

Alexander Blostein Upgraded (TW) to Strong Buy and Increased Target to $53 on, Nov 20th, 2019

by: WOPRAI

Katy Huberty Maintained (STX) at Buy with Increased Target to $66 on, Nov 20th, 2019

by: WOPRAI

David Havens Initiated (BKR) at Strong Buy and Held Target at $32 on, Nov 20th, 2019

by: WOPRAI

Ronald Epstein Reiterated (AER) at Strong Buy with Increased Target to $77 on, Nov 20th, 2019

by: WOPRAI

Steven Koenig Reiterated (ADSK) at Hold with Increased Target to $162 on, Nov 20th, 2019

by: WOPRAI

Matthew Broome Maintained (ADSK) at Strong Buy with Increased Target to $190 on, Nov 20th, 2019

by: WOPRAI

Toni Kaplan Maintained (ARMK) at Hold with Increased Target to $46 on, Nov 20th, 2019

by: WOPRAI

Chris Snyder Initiated (VAL) at Hold on, Nov 20th, 2019

by: WOPRAI

Jen Redding Maintained (URBN) at Hold with Decreased Target to $28 on, Nov 20th, 2019

by: WOPRAI

Tiffany Kanaga Maintained (URBN) at Hold with Decreased Target to $26 on, Nov 20th, 2019

by: WOPRAI

Paul Lejuez Maintained (URBN) at Hold with Increased Target to $25 on, Nov 20th, 2019

by: WOPRAI

Bryan Bergin Maintained (ACN) at Buy with Increased Target to $215 on, Nov 20th, 2019

by: WOPRAI

Brett Huff Maintained (ACIW) at Buy with Increased Target to $41 on, Nov 20th, 2019

by: WOPRAI

Michael Feniger Reiterated (ACM) at Strong Buy with Increased Target to $49 on, Nov 20th, 2019

by: WOPRAI

Andrew Baum Maintained (ABBV) at Strong Buy with Increased Target to $98 on, Nov 20th, 2019

by: WOPRAI

Jeff Kessler Maintained (ZBRA) at Buy with Increased Target to $265 on, Nov 20th, 2019

by: WOPRAI

Charles Zhu Initiated (ZYME) at Strong Buy and Held Target at $48 on, Nov 20th, 2019

by: WOPRAI

Jialong Shi Maintained (BILI) at Strong Buy with Increased Target to $20 on, Nov 20th, 2019

by: WOPRAI

George Tong Initiated (BCO) at Strong Buy and Held Target at $108 on, Nov 20th, 2019

by: WOPRAI

Joanna Gajuk Reiterated (AMED) at Strong Buy with Increased Target to $170 on, Nov 20th, 2019

by: WOPRAI

Leland Gershell Initiated (ALNY) at Buy and Held Target at $128 on, Nov 20th, 2019

by: WOPRAI

Leland Gershell Initiated (AMRN) at Sell and Held Target at $7 on, Nov 20th, 2019

by: WOPRAI

Alexander Blostein Downgraded (CBOE) to Hold and Held Target at $127 on, Nov 20th, 2019

  • Thu, November 21, 2019

by: WOPRAI

Felix Boeschen Initiated (ALSN) at Buy and Held Target at $50 on, Nov 21st, 2019

by: WOPRAI

Olivia Brayer Maintained (ALNY) at Buy with Increased Target to $159 on, Nov 21st, 2019

by: WOPRAI

David Lebovitz Maintained (ALNY) at Buy with Increased Target to $141 on, Nov 21st, 2019

by: WOPRAI

Do Kim Maintained (ALNY) at Buy with Increased Target to $138 on, Nov 21st, 2019

by: WOPRAI

Timothy Arcuri Downgraded (AMAT) to Strong Sell and Decreased Target to $48 on, Nov 21st, 2019

by: WOPRAI

Gus Richard Downgraded (AMD) to Hold and Held Target at $36 on, Nov 21st, 2019

by: WOPRAI

Seldon Clarke Initiated (BECN) at Hold and Held Target at $39 on, Nov 21st, 2019

by: WOPRAI

Armintas Sinkevicius Maintained (VC) at Sell with Increased Target to $52 on, Nov 21st, 2019

by: WOPRAI

Kimberly Greenberger Maintained (URBN) at Buy with Decreased Target to $32 on, Nov 21st, 2019

by: WOPRAI

Adam Jonas Maintained (ADNT) at Sell with Increased Target to $17 on, Nov 21st, 2019

by: WOPRAI

Seldon Clarke Initiated (TREX) at Hold on, Nov 21st, 2019

David Lebovitz Maintained (ASND) at Buy with Increased Target to $134 on, Nov 20th, 2019

David Lebovitz of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $128 to $134 on, Nov 20th, 2019.

David has made no other calls on ASND in the last 4 months.



There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David

  • Liana Moussatos of "Wedbush" Maintained at Buy with Decreased Target to $186 on, Tuesday, October 22nd, 2019
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $152 on, Thursday, August 29th, 2019